Investigators researching virtual reality technology with a human subject

High tech, high touch

A COMMUNITY OF CURIOSITY

Sara Snow with her research poster at the GIM Department of Medicine Research Day

Research

Pioneering spirit, bold innovation

Breakthroughs start with novel questions.

A scientific team reviewing documents together

Researchers at the David Geffen School of Medicine at UCLA redefine what is possible in patient care. They elucidate biological processes and solve medical mysteries, expanding knowledge to heal humankind—one breakthrough at a time.

Our researchers have access to top minds, unparalleled partnership opportunities, and state-of-the-art equipment. This is where high tech meets high touch, you are never alone on your scientific quest here.

$559M

DGSOM, National Institutes of Health Research Funding, 2022

#14

Most diverse medical school, U.S. News & World Report, 2022

36

National Academy of Medicine Members

20

National Academy of Sciences Members

See more rankings

A PIONEERING SPIRIT

The David Geffen School of Medicine at UCLA is one of the premier research and educational institutions in the nation. Our dedicated faculty is committed to providing excellence in teaching our trainees who are pursuing their careers in medicine and in the biomedical sciences. Our research scientists regularly make important new advances that benefit patients, worldwide, and society, in general.

An UCLA blue toned graphic of Paul Terasaki with various shapes and images, representing his 1964 breakthrough

Tissue Matching

1964: Paul Terasaki develops a tissue test that transforms organ transplantation.

See All Breakthroughs

A UCLA yellow toned graphic with Owen Witte with shapes and other images, representing his 1983 breakthrough

Landmark leukemia drug

1983: Owen Witte pinpoints a genetic target crucial to the development of life-saving drugs.

See All Breakthroughs

A teal toned graphic of David Eisenberg with shapes and various imagery, representing his 2005 breakthrough

Alzheimer’s research

2005: David Eisenberg’s model of amyloid fibers opens new avenues for treating neurodegenerative diseases.

See All Breakthroughs

A yellow toned graphic of Donald Kohn with shapes and various imagery, representing his 2015 breakthrough

Successful gene therapy

2015: Donald Kohn cures “Bubble Baby” disease using gene therapy.

See All Breakthroughs

Aerial shot of campus with many innovation hubs marked to show how close potential partnerships are. The phrase, 'innovation is a short walk away' is superimposed

Big discoveries begin on a collaborative campus

Our compact campus is home to leading experts in public health, engineering, computation, genetics, and other fields. Walk to a range of innovation hubs in less than 5 minutes. Collaborations and life-changing conversations are just a short walk away.

"To walk a few yards down the hall and talk to a collaborator who already knows how to do the technique you are interested in. That could save you years."

CHRISTINA CHARLES-SCHOEMAN, MD, CHIEF, DIVISION OF RHEUMATOLOGY